News Daily News Financial Strain Ups Risk of Death After Acute MI in the Elderly L.A. McKeown February 25, 2022
News Daily News FDA Approves Empagliflozin for Treatment of HFpEF Michael O'Riordan February 24, 2022
News Conference News THT 2022 Probe Beyond Ejection Fraction to Understand and Manage HFpEF L.A. McKeown February 07, 2022
News Daily News In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report Michael O'Riordan January 27, 2022
News Daily News As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control Caitlin E. Cox January 10, 2022
News Daily News Discharge Safe as Early as a Day After Primary PCI for STEMI L.A. McKeown December 15, 2021
News Daily News Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF L.A. McKeown December 07, 2021
News Conference News AHA 2021 Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF Michael O'Riordan November 19, 2021
News Conference News AHA 2021 Canagliflozin Improves Quality of Life in HF Patients Michael O'Riordan November 16, 2021
News Daily News Stressed Out Stable CAD Patients Have Higher Risk of MI and CV Death L.A. McKeown November 11, 2021
News Opinion Editor's Corner AHA 2021 AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More Shelley Wood November 08, 2021
News Conference News TCT 2021 GUIDE-HF Hints That Hemodynamic-Guided Management Works in HFpEF Michael O'Riordan November 06, 2021
News Daily News HFSA 2021 In HF and Diabetes, Mobile Health App Modestly Boosts Physical Activity Michael O'Riordan September 15, 2021
News Conference News HFSA 2021 Digital App Improves HF Quality-of-Care Metrics: CONNECT-AF Michael O'Riordan September 14, 2021